Insider Transactions in Q2 2020 at Moderna, Inc. (MRNA)
Insider Transaction List (Q2 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
39,752
-50.44%
|
$2,504,376
$63.65 P/Share
|
|
Jun 30
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
39,752
+39.11%
|
$755,288
$19.15 P/Share
|
|
Jun 26
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.68%
|
$662,760
$60.81 P/Share
|
|
Jun 25
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$670,000
$67.0 P/Share
|
|
Jun 24
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.01%
|
-
|
|
Jun 24
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.13%
|
$567,000
$63.25 P/Share
|
|
Jun 24
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.08%
|
$325,000
$65.09 P/Share
|
|
Jun 23
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.08%
|
$320,000
$64.16 P/Share
|
|
Jun 23
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
39,752
-83.6%
|
$2,544,128
$64.16 P/Share
|
|
Jun 23
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
39,752
+39.11%
|
$755,288
$19.15 P/Share
|
|
Jun 22
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
4,521
-0.05%
|
$293,865
$65.92 P/Share
|
|
Jun 19
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.0%
|
$717,990
$65.04 P/Share
|
|
Jun 18
2020
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
64,000
-98.95%
|
$4,032,000
$63.03 P/Share
|
|
Jun 18
2020
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
64,000
+49.74%
|
$896,000
$14.85 P/Share
|
|
Jun 16
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
39,752
-81.31%
|
$2,544,128
$64.94 P/Share
|
|
Jun 16
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
39,752
+39.11%
|
$755,288
$19.15 P/Share
|
|
Jun 15
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.08%
|
$325,000
$65.35 P/Share
|
|
Jun 12
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.66%
|
$684,852
$62.03 P/Share
|
|
Jun 12
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.08%
|
$305,000
$61.96 P/Share
|
|
Jun 10
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
3,435
-0.04%
|
$199,230
$58.8 P/Share
|
|
Jun 09
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
39,752
-88.58%
|
$2,305,616
$58.64 P/Share
|
|
Jun 09
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
39,752
+39.11%
|
$755,288
$19.15 P/Share
|
|
Jun 05
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.64%
|
$640,668
$58.15 P/Share
|
|
Jun 02
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
98,956
-52.31%
|
$5,739,448
$58.1 P/Share
|
|
Jun 02
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
98,956
+41.1%
|
$1,484,340
$15.19 P/Share
|
|
Jun 02
2020
|
Lorence H. Kim Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
241,000
-16.7%
|
$13,978,000
$58.3 P/Share
|
|
Jun 02
2020
|
Lorence H. Kim Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
241,000
+5.57%
|
$4,097,000
$17.51 P/Share
|
|
Jun 01
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
14,634
-0.09%
|
$907,308
$62.67 P/Share
|
|
Jun 01
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,878
-0.07%
|
$302,436
$62.67 P/Share
|
|
May 29
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.63%
|
$640,668
$58.84 P/Share
|
|
May 27
2020
|
Lorence H. Kim Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
241,000
-16.7%
|
$12,291,000
$51.13 P/Share
|
|
May 27
2020
|
Lorence H. Kim Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
241,000
+7.39%
|
$3,133,000
$13.22 P/Share
|
|
May 26
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.06%
|
$620,000
$62.05 P/Share
|
|
May 26
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
125,044
-100.0%
|
$8,252,904
$66.54 P/Share
|
|
May 26
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
125,044
+44.87%
|
$1,625,572
$13.22 P/Share
|
|
May 22
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.47%
|
$762,174
$69.16 P/Share
|
|
May 22
2020
|
Flagship Ventures Fund Iv General Partner LLC Director |
SELL
Open market or private sale
|
Indirect |
500,000
-0.78%
|
$34,500,000
$69.81 P/Share
|
|
May 21
2020
|
Flagship Ventures Fund Iv General Partner LLC Director |
SELL
Open market or private sale
|
Indirect |
500,000
-0.26%
|
$34,500,000
$69.36 P/Share
|
|
May 20
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
12,558
-0.08%
|
$879,060
$70.0 P/Share
|
|
May 20
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,186
-0.06%
|
$293,020
$70.0 P/Share
|
|
May 20
2020
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
64,000
-100.0%
|
$4,480,000
$70.0 P/Share
|
|
May 20
2020
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
64,000
+50.0%
|
$896,000
$14.85 P/Share
|
|
May 19
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
125,044
-100.0%
|
$9,753,432
$78.16 P/Share
|
|
May 19
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
125,044
+48.68%
|
$1,500,528
$12.21 P/Share
|
|
May 18
2020
|
Lorence H. Kim Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
241,000
-1.63%
|
$19,762,000
$82.14 P/Share
|
|
May 18
2020
|
Lorence H. Kim Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
241,000
+7.55%
|
$3,133,000
$13.22 P/Share
|
|
May 15
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.46%
|
$717,990
$65.5 P/Share
|
|
May 15
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,577
-0.02%
|
-
|
|
May 15
2020
|
Lorence H. Kim Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-0.41%
|
$1,300,000
$65.37 P/Share
|
|
May 13
2020
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
127,500
-46.37%
|
$8,160,000
$64.23 P/Share
|